pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2014-0-6-56-59pulmo-493Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESЭффективность проведения иммунизации против пневмококковой инфекции у работников алюминиевого производстваEfficacy of immunization against pneumococcal infection in aluminum industry workersСпиридоновВ. Л.SpiridonovV. L.

к. м. н., начальник отдела медицины труда ООО Медицинский центр "РУСАЛ"; тел.: (495) 720-51-70, доб. 52-99

PhD, Head of Occupational Medicine Department, LLC Medical Center RUSAL; tel.: (495) 720-51-70, ext. 52-99

Vladimir.Spiridonov@rusal.comРослаяН. А.RoslayaN. A.

д. м. н., профпатолог ГБУЗ СО "Свердловская областная клиническая больница No 1"; тел.: (343) 351-02-89;

MD, occupational physician, State Budget Healthcare Institution of Sverdlovsk region "Sverdlovsk regional clinical hospital N1"; tel.: (343) 351-02-89

roslaya.natalia@e1.ruАкопянК. А.AkopyanK. A.

зам. главного врача по медицинской части ООО Медицинский центр "РУСАЛ"; тел.: (391) 256-44-19

Deputy Chief Medical Officer, LLC Medical Center RUSAL; tel.: (391) 256-44-19

Kristina.Akopyan@rusal.comБушуеваТ. В.BushuevaT. V.

к. м. н., иммунолог ФБУН "Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промпредприятий" Роспотребнадзора; тел.: (343) 37187-54

PhD, immunologist, Federal State Budget Scientific institution "Ekaterinburg Medical and Scientific Center of Disease Prevention and Healthcare of Industrial Workers", Federal Service for Supervision of Consumer Rights Protection and Human Welfare; tel.: (343) 371-87-54

vv.66@mail.ruООО Медицинский центр "РУСАЛ": 660111, Красноярск, ул. Пограничников, 40РоссияLLC Medical Center RUSAL: 40, Pogranichnikov ul., Krasnoyarsk, 660111, RussiaRussian FederationГБУЗ СО "Свердловская областная клиническая больница No1": 620102, Екатеринбург, ул. Волгоградская, 189РоссияState Institution of Sverdlovsk region "Sverdlovsk regional clinical hospital N 1": 189, Volgogradskaya ul., Ekaterinburg, 62000, RussiaRussian FederationФБУН "Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промпредприятий" Роспотребнадзора: 620014, Екатеринбург, ул. Попова, 30РоссияFederal Institution "Ekaterinburg Medical and Scientific Center of Disease Prevention and Healthcare of Industrial Workers", Federal Service for Supervision of Consumer Rights Protection and Human Welfare: 30, Popova ul., Ekaterinburg, 620014, RussiaRussian Federation201428122014065659Copyright © Спиридонов В.Л., Рослая Н.А., Акопян К.А., Бушуева Т.В., 20142014Спиридонов В.Л., Рослая Н.А., Акопян К.А., Бушуева Т.В.Spiridonov V.L., Roslaya N.A., Akopyan K.A., Bushueva T.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/493

В структуре временной нетрудоспособности на предприятиях алюминиевой промышленности лидируют болезни органов дыхания. Приводятся убедительные данные о высокой эффективности и безопасности противопневмококковой иммунизации у работников промышленных предприятий. При однократном применении вакцины «Пневмо-23» снижается как число новых случаев бронхолегочной заболеваемости, так и длительность обострения ХОБЛ. 

Respiratory diseases are the leading cause of morbidity of aluminum industry workers. Aim. Given this fact the authorities of LLC RUSAL decided to vaccinate aluminum industry workers using PPV. Methods. This study included 200 workers (157 males) with a history of frequent (three or more episodes per a year) acute respiratory infection (ARI) or community-acquired pneumonia (CAP) or with stable COPD. The participants' age was 22 to 65 years, the length of work was 2 to 44 years. Results. In a year after the vaccination, there was 5-fold decrease in frequencies of both ARI episodes and COPD exacerbations. The average duration of exacerbations decreased from 23.7 ± 2.5 to 14.8 ± 1.3 days. No-one case of CAP was diagnosed in vaccinated patients during 12 months after the vaccination. Conclusion. Vaccination with a single-dose PPV-23 could reduce respiratory morbidity both in term of rate and duration of COPD exacerbations. Vaccination was safe and effective. 

алюминиевая промышленностьвакцинацияпневмонияболезни органов дыханияэффективность иммунизацииaluminum industryvaccinationpneumoniarespiratory diseasesimmunization efficacyReferencesGlobal Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlGlobal Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. http://www.goldcopd. org/guidelines-global-strategy-for-diagnosis-management. htmlPalmer K.T., Mc Neill-Love R., Poole J.R. et al. Inflammatory responses to the occupational inhalation of metal fume. Eur. Respir. J. 2006; 27: 366–373.Palmer K.T., Mc Neill-Love R., Poole J.R. et al. Inflammatory responses to the occupational inhalation of metal fume. Eur. Respir. J. 2006; 27: 366–373.Palmer K.T., Cullinan P., Rise S. et al. Mortality from infectious pneumonia in metal workers: a comparison with deaths from asthma in occupations exposed to respiratory sensitizers. Thorax. 2009; 64: 983–986.Palmer K.T., Cullinan P., Rise S. et al. Mortality from infectious pneumonia in metal workers: a comparison with deaths from asthma in occupations exposed to respiratory sensitizers. Thorax. 2009; 64: 983–986.Wong А., Мarrie T.J., Kellner J.D. et al. Welders are at increased risk for invasive pneumococcal disease. Inter. J. Infect. Dis. 2010; 14: 796–799.Wong ?., ?arrie T.J., Kellner J.D. et al. Welders are at increased risk for invasive pneumococcal disease. Inter. J. Infect. Dis. 2010; 14: 796–799.Koornhof H.J., Madhi S.A., Feldman C. et al. A century of South African battles against the pneumococcus – "the Captain of Death". South Afr. J. Epidemiol. Infect. 2009; 24 (4): 7–19.Koornhof H.J., Madhi S.A., Feldman C. et al. A century of South African battles against the pneumococcus – "the Captain of Death". South Afr. J. Epidemiol. Infect. 2009; 24 (4): 7–19.Palmer K.T., Cosgrove M.P. Vaccinating welders against pneumonia. Occup. Med. 2012; 62: 325–330.Palmer K.T., Cosgrove M.P. Vaccinating welders against pneumonia. Occup. Med. 2012; 62: 325–330.Moberley S., Holden J., Tatham D.P., Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2013; 1: CD000422.Moberley S., Holden J., Tatham D.P., Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2013; 1: CD000422.Grabenstein J.D., Manoff S.B. Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults. Vaccine. 2012; 30: 4435–4444.Grabenstein J.D., Manoff S.B. Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults. Vaccine. 2012; 30: 4435–4444.ACIP Provisional Recommendations for Use of Pneumococcal Vaccines, December 2008. http://www.healthnet. com/static/general/unprotected/pdfs/national/its_your_life/ aicp_provisional_recom_pneumococcal.pdfACIP Provisional Recommendations for Use of Pneumococcal Vaccines, December 2008. http://www.healthnet. com/static/general/unprotected/pdfs/national/its_ your_life/aicp_provisional_recom_pneumococcal.pdfCenters for Disease Control and Prevention (CDC). Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23). MMWR. 2010; 59 (34): 1102–1106.Centers for Disease Control and Prevention (CDC). Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23). MMWR. 2010; 59 (34): 1102–1106.The Green Book. Immunisation against infectious disease. UK Department of Health. Chapter 25, Pneumococcal infection. p. 306.The Green Book. Immunisation against infectious disease. UK Department of Health. Chapter 25, Pneumococcal infection. p. 306.Игнатова Г.Л., Федосова Н.С., Степанищева Л.А. Профилактическое и терапевтическое использование пневмококковой вакцины у работающих на промышленном предприятии пациентов с хроническими бронхолегочными заболеваниями. Пульмонология. 2007; 3: 81–85.Ignatova G.L., Fedosova N.S., Stepanishcheva L.A. Preventive and therapeutic use of pneumococcal vaccine in industrial workers with chronic bronchopulmonary disease. Pul'monologiya. 2007; 3: 81–85 (in Russian).Рослый О.Ф., Лихачева Е.И., ред. Медицина труда при электролитическом получении алюминия: монография. Екатеринбург; 2011.Roslyy O.F., Likhacheva E.I., eds. Occupational medicine in aluminum electrolytic production: a monograph. Ekaterinburg; 2011 (in Russian).

The authors declare that there are no conflicts of interest present.